Axogen, Inc. (AXGN): Price and Financial Metrics

Axogen, Inc. (AXGN): $9.72

0.14 (+1.46%)

POWR Rating

Component Grades














  • AXGN scores best on the Sentiment dimension, with a Sentiment rank ahead of 84.47% of US stocks.
  • AXGN's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • AXGN's current lowest rank is in the Momentum metric (where it is better than 16.1% of US stocks).

AXGN Stock Summary

  • Axogen Inc's stock had its IPO on March 27, 1990, making it an older stock than 84.38% of US equities in our set.
  • With a year-over-year growth in debt of 29.78%, Axogen Inc's debt growth rate surpasses 77.91% of about US stocks.
  • In terms of volatility of its share price, AXGN is more volatile than 89.58% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Axogen Inc, a group of peers worth examining would be CSII, BIOC, TRUE, REKR, and VAPO.
  • Visit AXGN's SEC page to see the company's official filings. To visit the company's web site, go to

AXGN Valuation Summary

  • In comparison to the median Healthcare stock, AXGN's price/earnings ratio is 187.67% lower, now standing at -32.
  • Over the past 243 months, AXGN's price/earnings ratio has gone down 29.1.
  • Over the past 243 months, AXGN's price/sales ratio has gone up 4.9.

Below are key valuation metrics over time for AXGN.

Stock Date P/S P/B P/E EV/EBIT
AXGN 2021-08-31 5.4 5.9 -32.0 -35.9
AXGN 2021-08-30 5.2 5.7 -30.9 -34.7
AXGN 2021-08-27 5.3 5.9 -31.6 -35.4
AXGN 2021-08-26 5.1 5.6 -29.9 -33.5
AXGN 2021-08-25 5.2 5.7 -30.5 -34.2
AXGN 2021-08-24 5.1 5.6 -30.2 -33.8

AXGN Growth Metrics

    Its 4 year cash and equivalents growth rate is now at 99.98%.
  • Its 2 year price growth rate is now at -75.15%.
  • Its 2 year cash and equivalents growth rate is now at 37.09%.
Over the past 34 months, AXGN's revenue has gone up $37,395,859.

The table below shows AXGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 127.358 -13.405 -26.985
2021-09-30 128.316 -9.054 -27.709
2021-06-30 130.54 -6.06 -22.047
2021-03-31 119.076 -12.394 -22.254
2020-12-31 112.3 -9.626 -23.786
2020-09-30 107.967 -15.793 -24.814

AXGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AXGN has a Quality Grade of C, ranking ahead of 50.98% of graded US stocks.
  • AXGN's asset turnover comes in at 0.65 -- ranking 58th of 186 Medical Equipment stocks.
  • ADMT, NDRA, and APYX are the stocks whose asset turnover ratios are most correlated with AXGN.

The table below shows AXGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.650 0.821 -0.111
2021-03-31 0.625 0.816 -0.133
2020-12-31 0.633 0.808 -0.172
2020-09-30 0.651 0.806 -0.219
2020-06-30 0.661 0.808 -0.294
2020-03-31 0.706 0.829 -0.278

AXGN Price Target

For more insight on analysts targets of AXGN, see our AXGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $27.00 Average Broker Recommendation 1.43 (Moderate Buy)

AXGN Stock Price Chart Interactive Chart >

Price chart for AXGN

AXGN Price/Volume Stats

Current price $9.72 52-week high $22.82
Prev. close $9.58 52-week low $6.87
Day low $9.43 Volume 207,177
Day high $9.82 Avg. volume 346,053
50-day MA $8.31 Dividend yield N/A
200-day MA $10.96 Market Cap 408.06M

Axogen, Inc. (AXGN) Company Bio

AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company is based in Alachua, Florida.

AXGN Latest News Stream

Event/Time News Detail
Loading, please wait...

AXGN Latest Social Stream

Loading social stream, please wait...

View Full AXGN Social Stream

Latest AXGN News From Around the Web

Below are the latest news stories about Axogen Inc that investors may wish to consider to help them evaluate AXGN as an investment opportunity.

AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q4 2021 Results - Earnings Call Transcript

AxoGen, Inc. (AXGN) Q4 2021 Earnings Conference Call February 22, 2022, 16:30 ET Company Participants Ed Joyce - Director, IR Karen Zaderej - Chairman, President & CEO Peter Mariani - EVP & CFO Conference Call Participants David Turkaly - JMP Securities\ Erin Broderick - SVB Leerink Presentation Operator Greetings. Welcome...

SA Transcripts on Seeking Alpha | February 23, 2022

AxoGen (AXGN) Reports Q4 Loss, Tops Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of 38.46% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 22, 2022

Axogen, Inc. Reports 2021 Fourth Quarter and Full-Year Financial Results

ALACHUA, Fla. and TAMPA, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 and Business Highlights Net revenue was $31.5 million during the fourth quarter, a 3% decrease compared to fourth-quarter 2020 revenue of $32.5 million.Fourth qua

Yahoo | February 22, 2022

Meet Maria Martinez, a 2022 BusinessWoman of the Year honoree

Maria Martinez is the chief human resources officer for Axogen, a publicly traded biotechnology company headquartered in Alachua with a local campus in Tampa.

Yahoo | February 16, 2022

Earnings Preview: AxoGen (AXGN) Q4 Earnings Expected to Decline

AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 15, 2022

Read More 'AXGN' Stories Here

AXGN Price Returns

1-mo 34.63%
3-mo 3.51%
6-mo 1.36%
1-year -52.28%
3-year -54.26%
5-year -35.20%
YTD 3.74%
2021 -47.65%
2020 0.06%
2019 -12.43%
2018 -27.81%
2017 214.44%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5543 seconds.